Table 2:

Use of physician services, risk factor screening and risk factor management, by LHIN event rate group*

IndicatorLHIN event rate group; % of patientsp value for trend across LHINs
Low CVD event rateMedium CVD event rateHigh CVD event rateOverall
Physician services and risk factor screening
Visited a family physician (2006–2007)86.487.586.487.00.2
Annual visits to a family physician (2006–2007), no. per person4.23.63.53.80.01
Periodic health examination (2005–2007)63.856.248.557.4< 0.001
Visited a specialist (2006–2007)60.057.855.858.10.004
Annual visits to a specialist (2006–2007), no. per person1.81.61.41.60.003
Dyslipidemia screening (2005–2007)71.967.358.067.3< 0.001
Diabetes screening (2005–2007)73.669.960.469.6< 0.001
Risk factor management
Prescribed statins31.431.931.331.70.4
 LDL ≤ 2 mmol/L among statin users51.853.549.652.60.03
Among individuals with hypertension
 Prescribed ≥ 2 antihypertensive medications54.856.156.355.80.07
 Controlled blood pressure§67.465.053.364.40.04
 Annual visits to a family physician for hypertension, no. per person (2008–2012)1.10.90.81.00.005
Among individuals with diabetes
 Prescribed any antiglycemic medication70.970.174.170.80.03
 Prescribed any ACE inhibitor or ARB67.267.769.467.70.1
 Prescribed statins60.860.457.260.20.004
 HbA1C ≤ 7%58.259.660.859.30.7
  • Note: ACE = angiotensin-converting enzyme, ARB = angiotensin II receptor blocker, CI = confidence interval, CVD = cardiovascular disease, HbA1C = glycated hemoglobin, LDL = low-density lipoprotein, LHIN = Local Health Integration Network.

  • * Values are age- and sex-standardized to the 2006 Ontario census population.

  • Unless stated otherwise.

  • Prescribed medications are in the 100 days before Jan. 1, 2008 among ≥ 65 year olds on Jan. 1, 2007 (n = 984 101). Antihypertensive medications are among individuals prescribed at least 1 antihypertensive medication (n = 460 090). Medications and HbA1c ≤ 7% among individuals with diabetes are restricted to those with laboratory confirmed diabetes or a history of prescriptions for antiglycemic medications before Jan. 1, 2008 (n = 64 163). LDL ≤ 2 mmol/L and HbA1c ≤ 7% are based on the latest result available between 2008 and 2012. LDL ≤ 2 mmol/L is the target in Canadian Dyslipidemia Guidelines.6

  • § Defined as < 140/90 mm Hg based on the average of the 3 most recent measurements during 2008–2012 among hypertensive patients in the Electronic Medical Record Administrative data Linked Database (EMRALD).